A service from mySociety A service from mySociety

TheyWorkForYou

Menu

Meningitis: Vaccination

Treasury written question – answered at on 16 July 2014.

Alert me about debates like this

Photo of Tony Cunningham Tony Cunningham Labour, Workington

To ask the Chancellor of the exchequer when his Department received the business case for the meningococcal B vaccine; and when he expects to make a decision whether or not to approve the business case.

Photo of Danny Alexander Danny Alexander The Chief Secretary to the Treasury

On 21 March 2014, the Joint Committee on Vaccination and Immunisation (JCVI) recommended that there should be a national Meningococcal B immunisation programme for infants, if the vaccine, Bexsero ®, could be purchased at a cost-effective price. The Treasury is working closely with the Department of Health on this business case. The Government would like to secure the vaccine from the supplier at the cost-effective price recommended by the JCVI.

Does this answer the above question?

Yes1 person thinks so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.

Chancellor of the Exchequer

The chancellor of the exchequer is the government's chief financial minister and as such is responsible for raising government revenue through taxation or borrowing and for controlling overall government spending.

The chancellor's plans for the economy are delivered to the House of Commons every year in the Budget speech.

The chancellor is the most senior figure at the Treasury, even though the prime minister holds an additional title of 'First Lord of the Treasury'. He normally resides at Number 11 Downing Street.